The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice
Open accessAbstract
A physiological examination of mice harboring a null allele at the aryl hydrocarbon ( Ah ) locus revealed that the encoded aryl hydrocarbon receptor plays a role in the resolution of fetal vascular structures during development. Although the aryl hydrocarbon receptor is more commonly studied for its role in regulating xenobiotic metabolism and dioxin toxicity, a developmental role of this protein is supported by the observation that Ah null mice display smaller livers, reduced fecundity, and decreased body weights. Upon investigating the liver phenotype, we found that the decrease in liver size is directly related to a reduction in hepatocyte size. We also found that smaller hepatocyte size is the result of massive portosystemic shunting in null animals. Colloidal carbon uptake and microsphere perfusion studies indicated that 56% of portal blood flow bypasses the liver sinusoids. Latex corrosion casts and angiography demonstrated that shunting is consistent with the existence of a patent ductus venosus in adult animals. Importantly, fetal vascular structures were also observed at other sites. Intravital microscopy demonstrated an immature sinusoidal architecture in the liver and persistent hyaloid arteries in the eyes of adult Ah null mice, whereas corrosion casting experiments described aberrations in kidney vascular patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice null for Ahr exhibit a patent DV with 100% penetrance, though the AHR-driven genes responsible for shunt closer remain unknown.”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Lahvis et al., 2000
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The patent DV is one of the most easily assessed and penetrant AHR-mediated phenotypes (Harstad et al., 2006; Lahvis et al., 2000; Lahvis et al., 2005).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Lahvis et al., 2000
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Early characterization of these null mice from our own laboratory uncovered significant vascular phenotypes, including the patent ductus venosus (DV) in the liver and a hyaloid artery in the eye, both of which are normal fetal structures that typically resolve shortly after birth (Lahvis et al., 2000; Lahvis et al., 2005; J. V. Schmidt et al., 1996).”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Lahvis et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
A Survey of Exact Inference for Contingency Tables
Agresti, A. (1992) · Statistical Science · doi:10.1214/ss/1177011454 · Cited by 1,132
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
The PAS Superfamily: Sensors of Environmental and Developmental Signals
Gu, Y.-Z., Hogenesch, J. B., & Bradfield, C. A. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.519 · Cited by 1,044
Self-citationCloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
Hoffman, E. C., Reyes, H., Chu, F., Sander, F. C., Conley, L. H., Brooks, B. A., & Hankinson, O. (1991) · Science · doi:10.1126/science.1852076 · Cited by 958
Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 902
Self-citationFernández‐Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 835
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Burbach, K. M., Poland, A., & Bradfield, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8185 · Cited by 831
Self-citationMaltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., & Simon, M. C. (1997) · Nature · doi:10.1038/386403a0 · Cited by 781
Self-citation
Flagged first, then by citations
2 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- H C Pitot, T Goldsworthy, H A Campbell, A Poland Cancer Res 40, 3616–3620 (1980).
- M Chojkier, R J Groszmann Am J Physiol 240, G371–G375 (1981).
- A Agresti Stat Sci 7, 131–135 (1992).
- A Francavilla, P Ove, L Polimeno, M Coetzee, L Makowka, M Barone, D H Van Thiel, T E Starzl Transplant Proc 20, 494–497 (1988).
- L Dubuisson, P Bioulac-Sage, C Bedin, C Balabaud J Submicrosc Cytol 16, 283–287 (1984).
- R S McCuskey, W Ekataksin, A V LeBouton, J Nishida, M A Krasovich, D McDonnell, C Williams, O Koldovsky Cells of the Hepatic Sinusoid VI, eds E Wisse, D L Knook, C Balabaud (Kupffer Cell Foundation, Leiden), pp. 67–70 (1997).
- Y-Z Gu, J Hogenesch, C Bradfield Annu. Rev. Pharmacol. Toxicol. (Academic Press), pp. 519–561 (2000).
Cited by
Sorted by citations
Items 101–200 of 377
Aryl Hydrocarbon Receptor Activation Inhibits Regenerative Growth
Mathew, L. K., Andreasen, E. A., & Tanguay, R. L. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.018044 · Cited by 86
Andrieux, L. O., Langouët, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., & Guillouzo, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.934 · Cited by 85
Levine, A., Chen, L., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.461 · Cited by 84
Vásquez, A. A., Atallah‐Yunes, N., Smith, F. C., You, X., Chase, S. E., Silverstone, A. E., & Vikstrom, K. L. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:2:153 · Cited by 84
Harrill, J. A., Hukkanen, R. R., Lawson, M., Martin, G., Gilger, B., Soldatow, V., LeCluyse, E. L., Budinsky, R. A., Rowlands, J. C., & Thomas, R. S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.024 · Cited by 83
Self-citationImmunological Relevance of the Coevolution of IDO1 and AHR
Jaronen, M., & Quintana, F. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00521 · Cited by 85
Thackaberry, E. A., Jiang, Z., Johnson, C. D., Ramos, K. S., & Walker, M. K. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi301 · Cited by 79
Román, Á., Carvajal-González, J. M., Rico-Leo, E. M., & Fernández‐Salguero, P. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013292 · Cited by 81
microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment
Moffat, I. D., Boutros, P. C., Celius, T., Lindén, J., Pohjanvirta, R., & Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm189 · Cited by 79
Kurita, H., Yoshioka, W., Nishimura, N., Kubota, N., Kadowaki, T., & Tohyama, C. (2009) · Journal of Applied Toxicology · doi:10.1002/jat.1459 · Cited by 78
The Evolving Role of the Aryl Hydrocarbon Receptor (AHR) in the Normophysiology of Hematopoiesis
Lindsey, S. C., & Papoutsakis, E. T. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9384-5 · Cited by 80
Differential Activities of Murine Single Minded 1 (SIM1) and SIM2 on a Hypoxic Response Element
Woods, S. L., & Whitelaw, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110752200 · Cited by 76
Bergander, L. V., Cai, W., Klocke, B., Seifert, M., & Pongratz, I. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1351 · Cited by 74
Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases
Tao, Y., Wang, J., Zhu, K., Tang, Y., Huang, S., Shui, X., Ding, Y., Chen, C., & Lei, W. (2018) · BioMed Research International · doi:10.1155/2018/6058784 · Cited by 76
Human Aryl Hydrocarbon Receptor Polymorphisms That Result in Loss of CYP1A1 Induction
Wong, J. M. Y., Okey, A. B., & Harper, P. A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5861 · Cited by 73
Gómez-Durán, Á., Carvajal-González, J. M., Mulero‐Navarro, S., Santiago‐Josefat, B., Puga, A., & Fernández‐Salguero, P. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.032 · Cited by 73
The aryl hydrocarbon receptor in liver inflammation
Carambia, A., & Schuran, F. A. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00867-8 · Cited by 74
Transcriptional regulation of small HSP—HSF1 and beyond
de Thonel, A., Mouël, A. L., & Mezger, V. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.012 · Cited by 74
Nakayama, K., Oshima, Y., Nagafuchi, K., Hano, T., Shimasaki, Y., & Honjo, T. (2005) · Environmental Toxicology and Chemistry · doi:10.1897/04-157r.1 · Cited by 69
Ryan, E. P., Holz, J. D., Mulcahey, M. K., Sheu, T., Gasiewicz, T. A., & Puzas, J. E. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070615 · Cited by 68
Aryl hydrocarbon receptor (AhR) ligands as selective AhR modulators: Genomic studies
Safe, S. H., Han, H., Goldsby, J. S., Mohankumar, K., & Chapkin, R. S. (2018) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2018.11.005 · Cited by 70
The Aryl Hydrocarbon Receptor Predisposes Hepatocytes to Fas-Mediated Apoptosis
Park, K., Mitchell, K. A., Huang, G., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005223 · Cited by 68
Sequence variation and phylogenetic history of the mouse Ahr gene
Thomas, R. S., Penn, S. G., Holden, K., Bradfield, C. A., & Rank, D. R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200203000-00009 · Cited by 67
Self-citationMattingly, C. J., McLachlan, J. A., & Toscano, W. A. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109845 · Cited by 67
Nishizawa, H., Morita, M., Sugimoto, M., Imanishi, S., & MANABE, N. (2005) · Journal of Reproduction and Development · doi:10.1262/jrd.16008 · Cited by 67
Nishizawa, H., Imanishi, S., & MANABE, N. (2005) · Journal of Reproduction and Development · doi:10.1262/jrd.17026 · Cited by 67
Hayes, K. R., Vollrath, A. L., Zastrow‐Hayes, G., McMillan, B. J., Craven, M. W., Jovanovich, S. B., Rank, D. R., Penn, S., Walisser, J. A., Reddy, J. K., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009175 · Cited by 67
Self-citationAndreasen, E. A., Mathew, L. K., Löhr, C. V., Hasson, R., & Tanguay, R. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl119 · Cited by 66
Vascular Endothelial Growth Factor Expression and Signaling in the Lens
Shui, Y., Wang, X., Hu, J. S., Wang, S., Garcia, C. M., Potts, J. D., Sharma, Y., & Beebe, D. C. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1226 · Cited by 65
Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase
Andreola, F., Hayhurst, G. P., Luo, G., Ferguson, S., Gonzalez, F. J., Goldstein, J. A., & Luca, L. M. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305832200 · Cited by 65
Furness, S. G. B., & Whelan, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.004 · Cited by 63
Nohara, K., Pan, X.-Q., Tsukumo, S., Hida, A., Ito, T., Nagai, H., Inouye, K., Motohashi, H., Yamamoto, M., Fujii-Kuriyama, Y., et al. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.5.2770 · Cited by 67
Vuori, K. A. M., Soitamo, A. J., Vuorinen, P. J., & Nikinmaa, M. (2004) · Aquatic Toxicology · doi:10.1016/j.aquatox.2004.03.019 · Cited by 65
Induction of Oxidative Stress Responses by Dioxin and other Ligands of the Aryl Hydrocarbon Receptor
Reichard, J. F., Dalton, T. P., Shertzer, H. G., & Puga, A. (2005) · Dose-Response · doi:10.2203/dose-response.003.03.003 · Cited by 65
Relevance of the Aryl Hydrocarbon Receptor (AhR) for Clinical Toxicology
Bradshaw, T. D., & Bell, D. R. (2009) · Clinical Toxicology · doi:10.1080/15563650903140423 · Cited by 62
The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular physiology
Zhang, N. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.83033 · Cited by 62
Sauzeau, V., Carvajal-González, J. M., Riolobos, A. S., Sevilla, M. A., Menacho-Márquez, M., Román, Á., Abad, A., Montero, M. J., Fernández‐Salguero, P. M., & Bustelo, X. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187534 · Cited by 67
Congenital Portosystemic Shunts
McLin, V. A., Franchi‐Abella, S., Debray, D., Guérin, F., Beghetti, M., Savale, L., Wildhaber, B. E., Gonzales, E. M., & Members of the International Registry of Congenital Porto‐Systemic Shunts (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002263 · Cited by 61
Diani-Moore, S., Labitzke, E., Brown, R., Garvin, A. J., Wong, L., & Rifkind, A. B. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj065 · Cited by 62
Nukaya, M., Lin, B. C., Glover, E. A., Moran, S. M., Kennedy, G. D., & Bradfield, C. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132043 · Cited by 60
Self-citationTaguchi, K., & Kensler, T. W. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01192-3 · Cited by 60
Loertscher, J. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.465 · Cited by 59
Thackaberry, E. A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg229 · Cited by 58
Boutros, P. C., Bielefeld, K. A., Pohjanvirta, R., & Harper, P. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp191 · Cited by 61
The C57BL/6J Mouse Exhibits Sporadic Congenital Portosystemic Shunts
Cudalbu, C., McLin, V. A., Lei, H., Duarte, J. M. N., Rougemont, A., Oldani, G., Terraz, S., Toso, C., & Rolf Gruetter, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069782 · Cited by 56
Barbieri, S. S., Ruggiero, L., Tremoli, E., & Weksler, B. B. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.159434 · Cited by 56
Chiaro, C. R., Patel, R. D., & Perdew, G. H. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049379 · Cited by 56
Liver Deformation in Ahr-Null Mice: Evidence for Aberrant Hepatic Perfusion In Early Development
Harstad, E. B., Guite, C. A., Thomae, T. L., & Bradfield, C. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020107 · Cited by 67
Self-citationMolecular Mechanisms of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Cardiovascular Embryotoxicity
Goldstone, H. M. H., & Stegeman, J. J. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570099 · Cited by 54
Jenny, M. J., Karchner, S. I., Franks, D. G., Woodin, B. R., Stegeman, J. J., & Hahn, M. E. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp116 · Cited by 54
Rojas, I. Y., Moyer, B. J., Ringelberg, C. S., Wilkins, O. M., Pooler, D. B., Ness, D. B., Coker, S. A., Tosteson, T. D., Lewis, L. D., Chamberlin, M. D., et al. (2021) · Obesity · doi:10.1002/oby.23065 · Cited by 53
Mohinta, S., Kannan, A., Gowda, K., Amin, S., Perdew, G. H., & August, A. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv046 · Cited by 58
Santiago‐Josefat, B., Mulero‐Navarro, S., Dallas, S. L., & Fernández‐Salguero, P. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.00932 · Cited by 53
Karyala, S. V., Guo, J., Sartor, M. A., Medvedovic, M., Puga, A., Ryan, P., & Tomlinson, C. R. (2004) · Cardiovascular Toxicology · doi:10.1385/ct:4:1:47 · Cited by 53
Agbor, L. N., Walsh, M. T., Boberg, J. R., & Walker, M. K. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.09.007 · Cited by 52
Domínguez-Acosta, O., Vega, L., Estrada‐Muñiz, E., Rodríguez, M. S., Gonzalez, F. J., & Elizondo, G. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.016 · Cited by 54
Role of Gene Knockout and Transgenic Mice in the Study of Xenobiotic Metabolism
Gonzalez, F. J. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026496 · Cited by 52
Cardiac Myocyte-Specific AHR Activation Phenocopies TCDD-Induced Toxicity in Zebrafish
Lanham, K. A., Plavicki, J. S., Peterson, R. E., & Heideman, W. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu111 · Cited by 51
Yang, S. Y. C., Ahmed, S., Satheesh, S. V., & Matthews, J. B. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2022-x · Cited by 49
Bock, K. W. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.021 · Cited by 55
Ma, Q. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00339-9 · Cited by 50
AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration
Mathew, L. K., Simonich, M. T., & Tanguay, R. L. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.025 · Cited by 50
Hillegass, J., Murphy, K. A., Villano, C. M., & White, L. A. (2006) · Biological Chemistry · doi:10.1515/bc.2006.144 · Cited by 53
Lund, A. K., Agbor, L. N., Zhang, N., Baker, A., Zhao, H., Fink, G. D., Kanagy, N. L., & Walker, M. K. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100586 · Cited by 50
Yim, S. H., Shah, Y., Tomita, S., Morris, D. H., Gavrilova, O., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2006) · Hepatology · doi:10.1002/hep.21284 · Cited by 49
Julliard, W. A., Wolfe, T. J. D., Fechner, J. H., Safdar, N., Agni, R. M., & Mezrich, J. D. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001830 · Cited by 50
Rojas, I. Y., Moyer, B. J., Ringelberg, C. S., & Tomlinson, C. R. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0512-z · Cited by 51
Jacob, A., Hartz, A. M. S., Potin, S., Coumoul, X., Yousif, S., Scherrmann, J., Bauer, B., & Declèves, X. (2011) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-8-23 · Cited by 55
Lin, B. C., Nguyen, L. P., Walisser, J. A., & Bradfield, C. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047068 · Cited by 48
Self-citationBrosens, J. J., & Parker, M. G. (2003) · Nature · doi:10.1038/423487a · Cited by 49
Kopec, A. K., Boverhof, D. R., Burgoon, L. D., Aibo, D. I., Harkema, J. R., Tashiro, C. H. M., Chittim, B. G., & Zacharewski, T. R. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm289 · Cited by 46
Zhang, N., & Walker, M. K. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-9007-6 · Cited by 46
Corchero, J., Martín‐Partido, G., Dallas, S. L., & Fernández‐Salguero, P. M. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00397.x · Cited by 47
Agbor, L. N., Elased, K. M., & Walker, M. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.011 · Cited by 45
Dioxin Exposure Disrupts the Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes
Wang, Y., Fan, Y., & Puga, A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfq038 · Cited by 44
Role of cAMP in mediating AHR signaling
Oesch‐Bartlomowicz, B., & Oesch, F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.017 · Cited by 46
Ichihara, S., Li, P., Mise, N., Suzuki, Y., Izuoka, K., Nakajima, T., Gonzalez, F. J., & Ichihara, G. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02446-1 · Cited by 43
Three-dimensional color power imaging of the fetal hepatic circulation
Kalache, K. D., Romero, R. J., Gonçalves, L. F., Chaiworapongsa, T., Espinoza, J., Schoen, M. L., Treadwell, M. C., & Lee, W. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00774-9 · Cited by 42
The influence of AHR on immune and tissue biology
Stockinger, B., Diaz, O. E., & Wincent, E. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00135-w · Cited by 43
The human AHR: identification of single nucleotide polymorphisms from six ethnic populations
Rowlands, C., Staskal, D. F., Gollapudi, B., & Budinsky, R. A. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833605f8 · Cited by 43
Falahatpisheh, M. H., & Ramos, K. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206238 · Cited by 41
d -Amino Acid Oxidase Generates Agonists of the Aryl Hydrocarbon Receptor from d -Tryptophan
Nguyen, L. P., Hsu, E. L., Chowdhury, G., Dostálek, M., Guengerich, F. P., & Bradfield, C. A. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900043s · Cited by 40
Self-citationMezrich, J. D., Nguyen, L. P., Kennedy, G., Nukaya, M., Fechner, J. H., Zhang, X., Xing, Y., & Bradfield, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044547 · Cited by 40
Self-citationWu, Y., Chen, X., Zhou, Q., He, Q., Kang, J., Zheng, J. J., Wang, K., & Duan, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086549 · Cited by 39
Ko, C., Wang, Q., Fan, Y., Xia, Y., & Puga, A. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.11.007 · Cited by 44
Chowdhury, G., Dostálek, M., Hsu, E. L., Nguyen, L. P., Stec, D. F., Bradfield, C. A., & Guengerich, F. P. (2009) · Chemical Research in Toxicology · doi:10.1021/tx9000418 · Cited by 38
Self-citationStobbe-Maicherski, N., Wolff, S., Wolff, C., Abel, J., Sydlik, U., Frauenstein, K., & Haarmann‐Stemmann, T. (2013) · FEBS Journal · doi:10.1111/febs.12571 · Cited by 41
Williams, R. S., Curnick, D. J., Barber, J. L., Brownlow, A. C., Davison, N. J., Deaville, R., Perkins, M. W., Jobling, S., & Jepson, P. D. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134835 · Cited by 38
Ishimura, R., Kawakami, T., Ohsako, S., Nohara, K., & Tohyama, C. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj138 · Cited by 38
Hayashida, Y., Kawamura, T., Hori-e, R., & Yamashita, I. (2004) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.21.541 · Cited by 37
Abnormalities of the umbilico‐portal venous system in Down syndrome: A report of two new patients
Pipitone, S., Garofalo, C., Corsello, G., Mongiovì, M., Piccione, M., Maresi, E., & Sperandeo, V. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20081 · Cited by 37
Nukaya, M., Walisser, J. A., Moran, S. M., Kennedy, G. D., & Bradfield, C. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq305 · Cited by 38
Self-citationGarcia, G. R., Shankar, P., Dunham, C. L., Garcia, A., Du, J. K. L., Truong, L., Tilton, S. C., & Tanguay, R. L. (2018) · Environmental Health Perspectives · doi:10.1289/ehp3281 · Cited by 37
Zhang, N., Agbor, L. N., Scott, J. A., Zalobowski, T., Elased, K. M., Trujillo, A., Duke, M. S., Wolf, V., Walsh, M. T., Born, J. L., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.023 · Cited by 35
Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes
Okey, A. B., Boutros, P. C., & Harper, P. A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200506000-00001 · Cited by 34
Moreno-Marín, N., Merino, J. M., Alvarez, A. M., Patel, D., Takahashi, S., González‐Sancho, J. M., Gandolfo, P., Rios, R. M., Múñoz, A., Gonzalez, F. J., et al. (2018) · iScience · doi:10.1016/j.isci.2018.05.006 · Cited by 37
AHR and the Transcriptional Regulation of Type-17/22 ILC
Lee, J. S., Cella, M., & Colonna, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00010 · Cited by 34
Teraoka, H., Ogawa, A., Kubota, A., Stegeman, J. J., Peterson, R. E., & Hiraga, T. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.05.003 · Cited by 34
van Steenbeek, F. G., den Bossche, L. V., Leegwater, P. A. J., & Rothuizen, J. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9364-0 · Cited by 33
Skoko, J., Wakabayashi, N., Noda, K., Kimura, S., Tobita, K., Shigemura, N., Tsujita, T., Yamamoto, M. P., & Kensler, T. W. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu109 · Cited by 32
Metadata
- Authors
- Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., & Bradfield, C. A.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Bradfield, Christopher A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-09-05
- Volume
- 97
- Issue
- 19
- Pages
- 10442-10447
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC27043
- OpenAlex
- W2163212976
- Cited by
- 377
- References
- 53
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 14 · 2017: 10 · 2016: 14 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 19
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Colgate-Palmolive Company
- National Institutes of Health (5p30ca007175-36, CA22484)
- National Cancer Institute (CA-07175, T32CA009681, CA 22484, P01CA022484)
- National Institute of Environmental Health Sciences (ES06883, F32ES005877, R01ES006883)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Cardiovascular Conditions and Treatments
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Keywords
- aryl hydrocarbon receptor, portosystemic shunt, patent ductus venosus, hyaloid artery, liver development, hepatocyte size, dioxin toxicity
- MeSH terms
- Animals, Arteries, Eye, Female, Kidney, Liver, Male, Mice, Inbred C57BL, Organ Size, Receptors, Aryl Hydrocarbon, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
